Sylvie Boyer

Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial

Collins Iwuji, Joanna Orne‐Gliemann, Joseph Larmarange et al. · The Lancet HIV · 2017 · 237 citations · Full text

Sexual Health, Rural South Africa, Preventive Medicine +9

Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon

Alexandra Calmy, Tamara Tovar-Sanchez, Charles Kouanfack et al. · The Lancet HIV · 2020 · 155 citations

Open Label, Week 96, Treatment And Prevention +10

Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial

Collins Iwuji, Joanna Orne‐Gliemann, Frank Tanser et al. · Trials · 2013 · 115 citations · Full text

Non-adherence to antiretroviral treatment and unplanned treatment interruption among people living with HIV/AIDS in Cameroon: Individual and healthcare supply-related factors

Sylvie Boyer, Isabelle Clerc, Cécile-Renée Bonono et al. · Social Science & Medicine · 2011 · 112 citations

Preventive Medicine, Hiv/aids Counselling, Health Policy +10

Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial

Christian Laurent, Charles Kouanfack, Gabrièle Laborde-Balen et al. · The Lancet Infectious Diseases · 2011 · 97 citations

Cd4 Cell Counts, Hiv/aids Counselling, Treatment And Prevention +8